HSBC Holdings
CVAC

HSBC Holdings’s CureVac CVAC Stock Holding History

HSBC Holdings’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-52,961
Closed -$418K – 3068
2022
Q3 		$418K Sell
52,961
-29,923
-36% -$349K ﹤0.01% 2252
2022
Q2 		$1.12M Buy
82,884
+80,164
+2,947% +$1.33M ﹤0.01% 1864
2022
Q1 		$53K Buy
2,720
+2,220
+444% +$44.3K ﹤0.01% 3195
2021
Q4 		$17K Sell
500
-26,335
-98% -$1.06M ﹤0.01% 3230
2021
Q3 		$1.48M Buy
26,835
+23,501
+705% +$1.42M ﹤0.01% 1680
2021
Q2 		$245K Buy
3,334
+2,535
+317% +$253K ﹤0.01% 2646
2021
Q1 		$73K Buy
+799
New +$77.5K ﹤0.01% 2650

Other funds holding CVAC

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HSBC Holdings's CVAC Position: Q4 2022 in Review

HSBC Holdings sold out of CureVac (CVAC) in Q4 2022, closing a stake of 52,961 shares — an estimated $418K sold.

HSBC Holdings first reported a position in CVAC in Q1 2021 and held it in 7 quarters. The position peaked at $1.48M in Q3 2021. 83 funds tracked by Wall St. Rank hold CVAC as of Q4 2022.

  • HSBC Holdings reported no remaining CureVac position as of Q4 2022 after selling out during the quarter.
  • HSBC Holdings sold 52,961 CureVac shares in Q4 2022, an estimated $418K.
  • HSBC Holdings first reported a position in CureVac in Q1 2021 and held it in 7 quarters.
  • HSBC Holdings's CureVac position peaked at $1.48M in Q3 2021.
  • 83 funds tracked by Wall St. Rank held CureVac as of Q4 2022.

Based on HSBC Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.